samedan logo
 
 
spacer
home > pmps > spring 2004 > outsourced manufacturing in life science: a modern industrial revolution?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Outsourced Manufacturing in Life Science: A Modern Industrial Revolution?

In this article we look at outsourcing of pharmaceutical production from a Euro-historical perspective, highlighting the pivotal position of clinical trial materials within the business mix for contractual manufacturing. In studying how the sector has evolved, we try to assess how market forces may shape its future.

About Outsourcing

Outsourcing, it could be said, isn't a new phenomenon, merely a new tag for an old dog. The question is: can one teach an old dog new tricks? Let's investigate. Firstly, to be clear about outsourcing, it's not about purchasing raw materials or active pharmaceutical ingredients (APIs), equipment or even laboratory apparatus. There's a subtle difference, and this simple analogy might help. It was once the norm to take delivery of fresh 'green' (non-pasteurised) milk directly from the farm, from urn to jug.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Charles Horth, Life Science Consulting Editor for Cytops, UK

Dr Charles Horth is Life Science Consulting Editor at Cytops, UK. Having gained a PhD in Biochemical Pharmacology, Charles has spent over 30 years in the life science industry after training in biochemistry, medical biochemistry and physiology. His industrial career began with market research in biotechnology, followed by laboratory instrument development. He subsequently worked for Vitamins Research (now part of GSK), CIBA-Geigy in Basel, Switzerland (now Novartis) and Searle, UK (now Pharmacia/Pfizer). Charles helped to set up and market a contract laboratory service for bioanalytical testing, metabolism studies, diagnostics and clinical development services.
spacer
Charles Horth
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration

Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with promising advantages that nasal route could offer, Nemera is thrilled to extend its portfolio by launching its unidose system, UniSpray, for systemic-acting drug administration to face emergency and crisis.
More info >>

White Papers

Streamlining patient recruitment using EHR data

The field of (bio)pharmaceutical research is booming. Increasingly more innovative therapeutics are being developed with the ability to drastically improve the quality of life of millions of patients around the world. Rigorously testing each of these candidate drugs for their safety and efficacy is an essential part of the development process. As the number of clinical trials steadily increases, the search for patients who present a specific medical profile and are willing to participate intensifies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement